Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: Cancer. 2011 Feb 1;117(15):3457–3467. doi: 10.1002/cncr.25884

Fig. 6. Treatment with SNDX-275 increases the sensitivity of LM7 cells to FasL without increasing Fas receptor expression on the cell surface.

Fig. 6

(A) LM7 cells were treated with 2̣ μM of SNDX-275 and Fas expression was detected at 48 h (dashed line), 72 hr (solid line). Untreated cells were used as control (grey shading). Fas expression on the cell surface was detected by flow cytometry. (B) LM7 cells were pretreated with 2 μM SNDX-275 for 48 h and then treated with 10 ng/ml soluble FasL for another 24 h. Untreated cells and cells treated with either agent were used as controls. The cell viability was detected by MTT assay.